Today The New York Times DealBook asks the question: Does it make sense to combine two booksellers with eroding sales and growing competition from the likes of Amazon.com and now [...]
Genzyme rejects Sanofi’s bear hug acquisition offer
by ,
August 30, 2010, 2:38 PM
0August 30, 2010, 2:38 PM
After years of bold proclamations of independence, another biotech may be in the throes of an inevitable takeover. Faced with manufacturing troubles, FDA investigations, and struggles with shareholders, Genzyme has [...]
Lofty Pfizer wipes out Wyeth
by ,
October 19, 2009, 3:04 PM
0October 19, 2009, 3:04 PM
Many large pharmaceutical mergers over the years have resulted in fused identities: 1989: Bristol-Myers + Squibb = Bristol-Myers Squibb 1999: Zeneca + Astra = AstraZeneca 2000: Glaxo Wellcome + SmithKline Beecham [...]
Intrigue in the data center (is IBM buying Sun?)
by ,
March 18, 2009, 11:21 AM
0March 18, 2009, 11:21 AM
IBM and Sun Microsystems may get hitched. Meanwhile, Cisco Systems is moving in on both companies’ bread-and-butter in server computers.
How about some good news? Well, okay, some not-so-bad news.
by ,
January 29, 2009, 1:37 PM
0January 29, 2009, 1:37 PM
The long-rumored merger between optical component suppliers Avanex and Bookham may finally happen. Get out the party hats!
Pfizer and Wyeth merger — could it be true (love)?
by ,
January 23, 2009, 9:24 AM
0January 23, 2009, 9:24 AM
Reading stories about drug-making behemoth Pfizer these days has me humming the tune “perhaps, perhaps, perhaps …” The Wall Street Journal is reporting this morning that Pfizer is in talks [...]
Bank of America struggles to digest Merrill Lynch
by ,
January 16, 2009, 8:52 AM
0January 16, 2009, 8:52 AM
I heard there’s a new movie coming out called Confessions of a Shopaholic, a chick flick starring Kenneth Lewis playing a gal who just can’t say no. Of course, wacky [...]
Will hostile takeovers become the norm for drugmakers?
by ,
August 27, 2008, 7:00 AM
2August 27, 2008, 7:00 AM
Consolidation is a practical solution when the competitive squeeze gets put on an industry, and large pharmaceutical companies are predictably falling into the acquisitive suitor role in an effort to [...]
Will Genentech take the Roche bait?
by ,
July 23, 2008, 7:00 AM
0July 23, 2008, 7:00 AM
There’s a lot of speculation circulating about whether leading biotechnology firm Genentech will accept pharmaceutical giant Roche’s $43.7 billion takeover bid, the largest pharma/biotech merger price tag in several years. [...]
Recent Comments